Position in PGEN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$554,279
+$112,511 QoQ
Shares Held
97,242
-14.8% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Derivatives in PGEN
reported options exposure · as of Dec 31, 2022CallValue
$0
CallShares
0
PutValue
$200
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. PGEN ranks #40 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in PGEN
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $554,279 | 97,242 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $441,768 | 114,152 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $437,060 | 104,560 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $330,023 | 100,311 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $282,327 | 198,822 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $285,859 | 191,852 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $214,898 | 191,874 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $182,536 | 192,144 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $105,858 | 66,999 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $100,195 | 69,100 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $115,043 | 85,853 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $104,377 | 73,505 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $88,389 | 76,860 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $83,305 | 78,590 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $200 | 1,000 | Put | Sole | 2023-02-09 | |
| 2022-12-31 | $118,072 | 77,679 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $291,603 | 137,549 | Shares | Sole | 2022-11-09 | |
| 2022-09-30 | $2,120 | 1,000 | Put | Sole | 2022-11-09 | |
| 2022-06-30 | $146,390 | 109,247 | Shares | Sole | 2022-08-10 | |
| 2022-06-30 | $15,000 | 100,000 | Call | Sole | 2022-08-10 | |
| 2022-03-31 | $147,695 | 69,998 | Shares | Sole | 2022-05-12 | |
| 2022-03-31 | $2,110 | 1,000 | Call | Sole | 2022-05-12 | |
| 2021-12-31 | $257,466 | 69,398 | Shares | Sole | 2022-02-10 | |
| 2021-12-31 | $3,710 | 1,000 | Put | Sole | 2022-02-10 | |
| 2021-09-30 | $297,144 | 59,548 | Shares | Sole | 2021-11-12 | |
| 2021-09-30 | $78,000 | 100,000 | Put | Sole | 2021-11-12 | |
| 2021-06-30 | $388,976 | 59,659 | Shares | Sole | 2021-08-06 | |
| 2021-06-30 | $110,000 | 100,000 | Call | Sole | 2021-08-06 | |
| 2021-03-31 | $430,755 | 62,519 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $537,733 | 52,719 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $205,516 | 58,719 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $290,532 | 58,223 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $194,558 | 57,223 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||